Bone News and Research

RSS

DFINE closes $25 million round of equity financing

DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, announced today the closing of a $25 million round of equity financing.

9 Nov 2011

Premier, RF Surgical sign three year agreement for detection technology

RF Surgical, Inc., the leader in prevention and detection of retained surgical items (RSI), today announced a three year agreement with the Premier healthcare alliance, a leader in healthcare performance improvement.

8 Nov 2011

Five-year results from Abbott's HUMIRA ATLAS study on ankylosing spondylitis

Abbott today announced five-year results from the open-label extension of the ATLAS study, which evaluated the long-term impact of treatment with HUMIRA (adalimumab) on disease activity, including spinal mobility in patients with active ankylosing spondylitis.

8 Nov 2011

Amgen plans $5 billion auction tender offer

Amgen today announced its plan to launch a modified Dutch auction tender offer to purchase up to $5 billion of its common stock, par value $0.0001 per share.

7 Nov 2011

Medtronic CoreValve System for direct aortic and subclavian implantation receives CE Mark

Medtronic, Inc. today announced it has received CE Mark for the Medtronic CoreValve System to be delivered using direct aortic access.

From Medtronic 7 Nov 2011

Pharmacyclics first quarter GAAP net loss increases to $14.5M

Pharmacyclics, Inc. today reported financial results and recent developments for its fiscal first quarter ended September 30, 2011.

7 Nov 2011

DuoCort Pharma granted marketing authorization for adrenal insufficiency drug, Plenadren in Europe

The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.

7 Nov 2011

MILV subsidiary acquires formula to restore proper kidney function

Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. announced that it has executed the formal closing documents and acquired the chronic kidney disease formula. This formula was developed to restore proper kidney function.

7 Nov 2011

Positive top-line results from NPSP558 Phase 3 study on hypoparathyroidism

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced positive top-line results from REPLACE, a Phase 3 registration study of NPSP558, the company's bioengineered replica of human parathyroid hormone (rhPTH 1-84), in adult hypoparathyroidism patients.

7 Nov 2011

New data from Novartis' ACZ885 Phase III study on SJIA

Novartis announced today new pivotal Phase III data showing 45% of children with active systemic juvenile idiopathic arthritis (SJIA) were able to substantially reduce their use of oral corticosteroids (often described as steroids) within 28 weeks of commencing treatment with ACZ885.

7 Nov 2011

$Narcotic analgesics increase risk of falls and fractures among elderly$

Narcotic analgesics increase risk of falls and fractures among elderly

Falls and fractures among senior citizens have increased since rofecoxib was removed from the market in 2004, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

Rheumavax safe and feasible in treating RA

A vaccine designed to re-educate the immune system has been shown to be safe and feasible in the treatment of rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

$Postmenopausal women with OA have higher risk of bone fractures, falls$

Postmenopausal women with OA have higher risk of bone fractures, falls

Postmenopausal women with osteoarthritis have a 20 percent higher risk of bone fractures and experience almost 30 percent more falls than those without the disease, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

Potential predictors of spinal damage progression in people with spondyloarthritis

The presence of syndesmophytes (bony growths in the spine), acute phase reactants (proteins that are released into the blood in response to inflammation), and smoking status can all serve as predictors for the progression of structural damage in the spine in people with spondyloarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

Final results from Vertex VX-509 Phase 2a study on RA

Vertex Pharmaceuticals Incorporated today announced the final results from a Phase 2a study of the investigational selective oral JAK3 inhibitor VX-509.

6 Nov 2011

$Women under 50 with RA more likely to have new fractures$

Women under 50 with RA more likely to have new fractures

Women under 50 with rheumatoid arthritis are at greater risk of breaking bones than women without the condition, according to a Mayo Clinic study being presented at the American College of Rheumatology annual scientific meeting in Chicago.

6 Nov 2011

Obesity raises risk of injury and related woes: Report

The Australian Institute of Health and Welfare said in its report, “Obesity and Injury in Australia: a Review of the Literature”, that in spite of the findings being mixed, the probability of falls, trips or stumbles rise with obesity. However, the Institute's James Harrison says the increased risk of injury from falls in the obese may be somewhat offset by the better cushioning body fat provides.

6 Nov 2011

K2M adds two additions to family of ALEUTIAN Interbody Systems for lumbar applications

K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today debuted two additions to the family of ALEUTIAN Interbody Systems at the 2011 North American Spine Society Annual Meeting in Chicago.

5 Nov 2011

Princeton University's bone marrow research to prevent breast cancer metastasis

Two teams of Princeton University researchers will study bone marrow to help explain and potentially prevent breast cancer from spreading, with national research funding announced today by Susan G. Komen for the Cure.

5 Nov 2011

Hawaii Pacific Health joins Premier's Partnership for Care Transformation collaborative

Hawaii Pacific Health has joined the Premier healthcare alliance's PACT (Partnership for Care Transformation) collaborative to build the necessary capabilities that are required under the final Medicare shared savings rule.

5 Nov 2011